Objective The prognostic value of metabolic parameters using 18F-fluorodeoxyglucose
positron emission tomography/computed tomography (FDG PET/CT) has not been …

Purpose Stereotactic body radiation therapy (SBRT) is considered the standard of care for
medically inoperable early-stage non-small cell lung cancer. There is mixed evidence on the …

Objective The aim of this study was to determine prognostic value of tumor size and
metabolic activity on survival for patients with early stage nonsmall cell lung cancer …

BACKGROUND AND PURPOSE: To test whether 18F-fluorodeoxyglucose (FDG) positron
emission tomography-computed tomography (PET-CT) imaging metrics correlate with …

Objectives The aim of this study was to evaluate the prognostic value of pretreatment 18 F-
fluorodeoxyglucose PET/computed tomography (CT), particularly in the assessment of …

Purpose 18 F-Fluorodeoxyglucose positron emission tomography (FDG PET) has been
used to assess metabolic response several months after stereotactic body radiotherapy …

Aims Stereotactic body radiotherapy (SBRT) is commonly considered an important treatment
option for patients with stage I non‐small cell lung cancer (NSCLC) who have …

Introduction: Stereotactic ablative radiotherapy (SABR) is a relatively new technique for the
curative-intent treatment of patients with inoperable early-stage non-small-cell lung cancer …

Background This retrospective study aims to assess the usefulness of SUV max from FDG-
PET imaging as a prognosticator for primary biopsy-proven stage I NSCLC treated with …

PURPOSE: To perform a retrospective review to determine whether maximum standardized
uptake values (SUVmax) from staging 2-deoxy-2-[18F] fluoro-D-glucose (FDG) positron …